It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Utilizing a novel microsimulation approach, this study evaluates the impact of fixed and average point-to-point Speed Enforcement Cameras (SEC) on driving safety. Using the SUMO software, agent-based models for a 6-km highway without exits or obstacles were created. Telematics data from 93,160 trips were used to determine the desired free-flow speed. A total of 13,860 scenarios were simulated with 30 random seeds. The ratio of unsafe driving (RUD) is the spatial division of the total distance travelled at an unsafe speed by the total travel distance. The study compared different SEC implementations under different road traffic and community behaviours using the Power Model and calculated crash risk changes. Results showed that adding one or two fixed SECs reduced RUD by 0.20% (0.18–0.23) and 0.57% (0.54–0.59), respectively. However, average SECs significantly lowered RUD by 10.97% (10.95–10.99). Furthermore, a 1% increase in telematics enforcement decreased RUD by 0.22% (0.21–0.22). Point-to-point cameras effectively reduced crash risk in all implementation scenarios, with reductions ranging from − 3.44 to − 11.27%, pointing to their superiority as speed enforcement across various scenarios. Our cost-conscious and replicable approach can provide interim assessments of SEC effectiveness, even in low-income countries.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Non-Communicable Diseases Research Center, Tehran, Iran (GRID:grid.411705.6) (ISNI:0000 0001 0166 0922); Shahid Beheshti University of Medical Sciences, Research Institute for Gastroenterology and Liver Diseases, Tehran, Iran (GRID:grid.411600.2)
2 Independent Researcher, Waterloo, Canada (GRID:grid.411600.2)
3 Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Non-Communicable Diseases Research Center, Tehran, Iran (GRID:grid.411705.6) (ISNI:0000 0001 0166 0922)
4 University of Chicago, Public Health Sciences, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822)
5 Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, USA (GRID:grid.67033.31) (ISNI:0000 0000 8934 4045)
6 Institute of Health, Shiraz University of Medical Sciences, Health Policy Research Center, Shiraz, Iran (GRID:grid.412571.4) (ISNI:0000 0000 8819 4698)
7 Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Non-Communicable Diseases Research Center, Tehran, Iran (GRID:grid.411705.6) (ISNI:0000 0001 0166 0922); Tehran University of Medical Sciences, Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran, Iran (GRID:grid.411705.6) (ISNI:0000 0001 0166 0922)